© 2020 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2020 MJH Life Sciences™ and Formulary Watch. All rights reserved.
September 28, 2020
Sun Pharmaceuticals issued a voluntary recall of 1 lot of its metformin hydrochloride for extended-release (ER) oral suspension (Riomet ER), 500 mg per 5 mL.
September 22, 2020
Some of the top medications were approved this summer, while others are awaiting FDA approval.
Both recalls are due to sub-potency of drugs that treat hypothyroidism.
September 15, 2020
The top-selling diabetes drug will join semaglutide (Ozempic), which is approved to reduce the risk of major adverse cardiovascular events.
September 14, 2020
The treatment is the first anti-PD-1 antibody from China to receive Breakthrough therapy designation.
September 08, 2020
Pharma makers expect the treatment to be available within a week.
The medication boasts a statistically significant improvement in overall survival versus placebo.
August 31, 2020
One study questions the effectiveness of remdesivir past day 10 while others support its expanded use.
August 28, 2020
The pharma maker will initially produce 150 million of the 5-minute tests.
August 18, 2020
Drug for a specific Duchenne muscular dystrophy mutation is only the second drug approved for the mutation.
August 17, 2020
The drug’s indication for marginal zone lymphoma (MZL) may not be approved until February 2021.
August 11, 2020
Evrysdi is only the second drug approved to treat the rare disease.
Olinvyk is the first new chemical entity in this IV drug class in decades.
August 04, 2020
The chimeric antigen receptor (CAR) T cell therapy is the first of its kind for mantle cell lymphoma (MCL).
Esketamine (Spravato) can now be used to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.
July 21, 2020
The drug is the first treatment approved for active psoriatic arthritis that selectively inhibits interleukin (IL)-23.
The PBM overcharged for generic drugs, among other offenses, a new lawsuit claims.
July 14, 2020
The pharma maker is partnering with the nonprofit Civica Rx to help reduce shortages in hospitals.
July 13, 2020
Five other manufacturers have recalled the popular diabetes medication due to the presence of a the carcinogenic ingredient.
July 07, 2020
Gilead will present new data on virologic suppression in adults 65 years and older at AIDS 2020: Virtual this week.